Insiders Neurogene Inc.

Equities

NGNE

US64135M1053

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 20/01/2026 GMT			5-day change	1st Jan Change
17.52 ^USD	-0.17%		+3.36%	-14.95%

01-12	Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-In-Class Gene Therapy for Rett Syndrome	CI
11-13	Gene therapy developer Neurogene's Q3 net loss widens	RE

Insiders

14/04/25	Neurogene Amends Agreement With Baker Bros To Increase Nomination Threshold	RE
21/02/24	Neurogene Inc. Appoints Donna Cochener as Senior Vice President, General Counsel	CI
17/01/24	Neurogene Inc. Appoints Julie Jordan as Chief Medical Officer	CI
16/01/24	Neurogene Names Julie Jordan as Chief Medical Officer	MT
16/01/24	Neurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical Officer	CI
03/04/23	Neoleukin Therapeutics, Inc. Appoints Sean Smith as Interim Chief Financial Officer	CI
03/04/23	Neoleukin Therapeutics, Inc. Appoints Donna M. Cochener as the Interim Chief Executive Officer	CI
10/03/23	Neoleukin Therapeutics, Inc. Announces Board Changes	CI
08/03/23	Neoleukin Therapeutics Weighs Potential Sale, Plans to Cut Workforce by 70%; CEO Drachman to Leave	MT
08/03/23	Neoleukin Therapeutics, Inc. Announces Stepping Down of Jonathan Drachman, M.D. as Chief Executive Officer	CI
15/03/22	Neoleukin Therapeutics, Inc. Appoints Donna M. Cochener as General Counsel, Senior Vice President Legal	CI
11/03/22	Neoleukin Therapeutics, Inc. Announces Management Changes	CI
01/03/22	Neoleukin Therapeutics Inc. Announces Executive Changes	CI
15/02/22	Neoleukin Therapeutics, Inc. Announces Resignation of Robert Ho as Corporate Secretary, Effective March 1, 2022	CI
19/11/21	Neoleukin Therapeutics, Inc. Announces Resignation of Holly Vance as General Counsel and Corporate Secretary	CI
07/06/21	Insider Trends: 90-Day Buying Trend Prolonged with Insider Purchase of Neoleukin Therapeutics Stock	MT
03/05/21	Neoleukin Therapeutics Announces Appointment of Priti Patel as Chief Medical Officer	CI
24/12/20	Insider Trends: Insider Acquisition Interrupts 90-Day Trend of Sales at Neoleukin Therapeutics	MT
20/10/20	Neoleukin Therapeutics Appoints Holly K. Vance as General Counsel	CI
10/09/20	Neoleukin Therapeutics, Inc. Announces Appointment of Martin Babler to Board of Directors	CI
01/06/20	Neoleukin Therapeutics, Inc. Announces Board Changes	CI
05/12/19	Neoleukin Therapeutics Announces Scientific Advisory Board	CI
19/09/19	Neoleukin Therapeutics Announces Additions to Management Team	CI
06/08/19	Aquinox Pharmaceuticals, Inc. and Neoleukin Therapeutics, Inc Announce Executive Appointments	CI
15/12/17	Aquinox Pharmaceuticals, Inc. Promotes Lloyd Mackenzie to Chief Operating Officer and Vice President, R&D Operations	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Insiders Neurogene Inc.

Equities

NGNE

US64135M1053

Biotechnology & Medical Research

Insiders

Filters